Hexagon Nutrition profitability ratios

·Pharma & HealthChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendFY26Mar 2026
Returns
16.3%
11.9%
17.4%
15.1%
Margins
13.8%
11.2%
13.4%
9.9%
9.9%
−0.3%
Additional
25.9%
16.3%
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

HEXAGON₹57.32

Hexagon Nutrition Limited

· Pharma & Health
₹ CroreMcap ₹634 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY26
31/03/2026
Returns
Return on Common Equity16.26
Return on Assets11.91
Return on Capital Employed17.39
Return on Invested Capital15.13
Margins
EBITDA Margin13.75
Operating Margin11.23
Pretax Margin13.38
Net Income Margin9.91
Net Income to Common Margin9.91
FCF Margin-0.30
Additional
Effective Tax Rate25.88
Sustainable Growth Rate16.26
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.